newdrugapprovals.org
EMA grants orphan drug designations to Alnylam’s ALN-AT3 for haemophilia treatment
EMA grants orphan drug designations to Alnylam’s ALN-AT3 for haemophilia treatment Biopharmaceutical company Alnylam Pharmaceuticals has received orphan drug designations for AL…